A Study of Emactuzumab and Atezolizumab Administered in Combination in Participants With Advanced Solid Tumors
Clinical trial NCT02323191 · COMPLETED
Trial details
- NCT number
- NCT02323191
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-19
- Primary completion
- 2020-08-21
- Enrollment
- 221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.